Oxtex Directors win Alpha Innovator of the Year Award
Oxtex is pleased to announce that the 2016 ICIS Alpha Innovator of the Year Award for Product/Process Development goes jointly to Mr Marc Swan and Professor Jan Czernuszka. Dr Swan is Oxtex's Clinical Director, and Professor Czernuszka is its Technical Director. It is their original meeting and work in the early 2000s that led to the development of intelligent self-inflating tissue expanders and the establishment of Oxtex.
The resulting veterinary product, Expaniderm, was launched in April this year.
"The initial response to the product has been very positive," said Professor Czernuszka. "Veterinary surgeons are able to solve problems in horses and dogs that they were never able to do before. We are also getting invaluable data that is helping further improve the technology – a win-win situation,"
Mr Swan is planning clinical studies for London in 2017, and Mr Zamri Radzi, a Malay dental surgeon is leading the ‘Malaysia cross bite’ trials.
Oxtex is aiming to achieve sales in human applications of some £100m by 2021 and to double this by 2025-26.
David Jackson, CEO of Oxtex said, "The unique and integral partnership between Swan and Czernuszka led to a pioneering novel solution for use in humans, and for the first time ever, in animal applications."
The ICIS award is one of a number that Oxtex has received since it was established in 2011.
ICIS is the world's largest petrochemical market information provider and has fast-growing energy and fertilizer divisions. It delivers trusted pricing data, high-value news, analysis and independent consulting and has more than 30 years' experience in providing pricing information, news, analysis and consulting to buyers, sellers and analysts.
Details of other winners are available on the ICIS awards site.